About the Journal

Frontiers in Clinical Trials and Drug Interactions (FCTDI) is an open-access, peer-reviewed journal published by Multiscia Journals, dedicated to advancing research in clinical trial design, drug safety, pharmacokinetics, and pharmacodynamics.

Topics include phase I–IV clinical trials, bioequivalence studies, adverse drug reactions, drug–drug interactions, personalized medicine, regulatory guidelines, and clinical pharmacology. The journal encourages evidence-based studies that enhance patient safety and therapeutic efficacy.

Key Features:

• Rigorous Peer Review: Ensuring reliability, ethics, and scientific merit.

• Open Access: Maximizing the accessibility of clinical research.

• Interdisciplinary Dialogue: Bridging medicine, pharmacology, and regulatory science.

• Global Perspective: Showcasing research from diverse healthcare settings.